Skip to content

Comparative Effect of Vojta Therapy and Bobath Therapy on Lower Limb Spasticity and Motorcity Among HS

Comparative Effect of Vojta Therapy and Bobath Therapy on Lower Limb Spasticity and Motorcity Among Hemiparetic Stroke Patients

Status
Active, not recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06905457
Enrollment
46
Registered
2025-04-01
Start date
2025-03-20
Completion date
2026-02-20
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Background: Stroke is clinical defined as a neurological syndrome characterized by acute disruption of blood flow to an area of brain and corresponding onset of neurological defects related to the concerned area of brain. Hemiplegic patient primarily affects the upper limb and lower limb of one side and typically results in flaccidity and difficulties with motor control and function.

Detailed description

The aim of this study will compare the Effect of Vojta therapy and Bobath therapy on lower limb spasticity and motorcity among hemiparetic stroke patients. Methodology: Randomize clinical trials will be carried out on lower limb spasticity and motorcity among hemiparetic stroke patients. This study will include adult's stroke (1-4 months post- onset). Inclusion criteria in which diagnosed with hemiplegic patients, aged 25-75 years and willingness to participants.

Interventions

COMBINATION_PRODUCTVojta therapy

Vojta therapy, also known as Reflex Locomotion Therapy, is a specialized physiotherapy technique developed by Czech neurologist Václav Vojta, using sensory stimulation to activate innate movement patterns and improve motor skills, posture, and overall function

COMBINATION_PRODUCTBobath therapy

Bobath therapy, also known as Neurodevelopmental Treatment (NDT), is a problem-solving approach to neurological rehabilitation, focusing on motor learning and efficient motor control to improve function and participation in daily activities

Sponsors

Superior University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
25 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Diagnosed with Hemiparetic stroke. * adult's stroke (1-4 months post- onset) * Ability to follow instructions and participate in testing * Aged 25-75 years.

Exclusion criteria

* Previous history of brain surgery. * Pregnant women. * Limitation in cognitive skills like Aphasia, deteriorated consciousness or dementia. * Severe cardiovascular disease (unstable hypertension)

Design outcomes

Primary

MeasureTime frameDescription
Fugl-Meyer Assessment scale(FMA)12 MonthsThe total possible scale score is 226. Points are divided among the domains as follows: Motor score: ranges from 0 (hemiplegia) to 100 points (normal motor performance). Divided into 66 points for upper extremity and 34 points for the lower extremity.
Modified ashworth scale( MAS)12 MonthsThe Modified Ashworth Scale (MAS) is a clinical tool used to measure spasticity, a velocity-dependent increase in muscle stretch reflexes, by assessing the resistance to passive movement. It's a six-level ordinal scale, ranging from 0 (no increase in tone) to 4 (affected part rigid)

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026